Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
Head & Neck Cancer
4 articles
Genetic Variants Linked to Higher Mortality Risk in Cancer Chemotherapy
Meta-analysis reveals DPYD gene variants significantly increase death risk in fluoropyrimidine chemotherapy.
Weekly Cisplatin: A Kidney-Friendly Approach for Head and Neck Cancer Treatment
Study finds weekly cisplatin reduces kidney injury risk without compromising survival in head/neck cancer.
Immunotherapy Breakthrough: Toripalimab Boosts Survival in Nasopharyngeal Cancer
Toripalimab plus chemotherapy significantly improves survival in recurrent/metastatic nasopharyngeal carcinoma.
L-Glutamine: A Safe Supplement for Head and Neck Cancer Patients Undergoing Chemoradiotherapy
Study finds L-glutamine supplementation does not negatively impact survival in head and neck cancer patients